Photo from Nathan A. Pennell/X
Jun 29, 2024, 08:58
Nathan Pennell: EGFR mutation testing, treatment and survival in stage I–III NSCLC
Nathan Pennell, Professor and Vice Chair of Clinical Research at Cleveland Clinic, shared on X: .
“Happy to see our paper out led by Bharathi Muthusamy.
EGFR mutation testing, treatment and survival in stage I–III non-small-cell lung cancer: CancerLinQ Discovery database retrospective analysis.”
Proceed to the article.
Source: Nathan Pennell/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14